BCYC · Bicycle Therapeutics PLC

$3.87 -0.08 (-1.90%) At close · Jul 29

Market Cap

$275.06M

69.81M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kevin Lee	CEO	$516,950	$63,907	—	$3,370,651	$368,484	$56,305	$4,376,296
Lee Kalowski	CFO	$416,568	—	—	$1,826,955	$237,610	—	$2,481,133
Michael Skynner	COO	$361,072	—	—	$1,192,094	$212,390	$52,572	$1,818,129

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Kevin Lee	CEO	$385,549	$127,630	—	—	$267,904	$36,811	$817,894
Lee Kalowski	CFO	$349,520	$60,000	—	—	$110,536	—	$520,056

Executive changes

Person	Role	Change	Effective	Filed
Jennifer Perry, Pharm.D.	Chief Operating Officer	Appointed	2026-03-17	2026-03-17
Travis Thompson	Chief Financial Officer	Appointed	2026-01-29	2026-02-03

Key facts CIK 1761612 CUSIP 088786108 13F (30d) 13 filings 13 filers Visit website